From: Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study
Characteristic | PMS cases n = 401 | Controls n = 401 | P value |
---|---|---|---|
 | Mean (SD) | Mean (SD) |  |
Age (years) | 40.6 (4.0) | 40.7 (3.8) | 0.94 |
Body mass index (kg/m2) | 25.7 (5.8) | 25.4 (5.8) | 0.50 |
Body mass index at age 18 (kg/m2) | 21.5 (3.4) | 21.4 (3.5) | 0.81 |
Age at menarche (years) | 12.5 (1.4) | 12.4 (1.5) | 0.45 |
Number of full term pregnancies | 2.0 (1.2) | 2.0 (1.3) | 0.43 |
Age at first birth (years)* | 26.2 (4.2) | 26.7 (4.1) | 0.11 |
Physical activity (MET/wk) | 18.7 (19.4) | 20.0 (20.8) | 0.36 |
Alcohol intake (grams/day) | 4.6 (6.8) | 3.7 (6.5) | 0.05 |
 | % | % |  |
White race | 96.0 | 98.8 | 0.02 |
Mother had > high school education | 31.9 | 39.9 | 0.02 |
More than 5 moles on lower leg†| 15.5 | 17.0 | 0.57 |
Low UV radiation index region of US | 22.2 | 26.0 | 0.22 |
Current smoker | 11.2 | 4.7 | <0.001 |
Former smoker | 30.7 | 15.7 | <0.001 |
Tubal ligation | 31.1 | 25.2 | 0.06 |
Significant childhood trauma | 18.1 | 5.6 | <0.001 |
Antidepressant use& | 14.7 | 6.2 | <0.001 |
Ever used oral contraceptives | 86.5 | 77.3 | <0.001 |
Calcium/vitamin D supplement use | 41.4 | 39.9 | 0.67 |
B vitamin supplement use | 17.7 | 10.0 | 0.002 |
Regular multivitamin use | 48.9 | 44.1 | 0.18 |
Biomarkers | Mean (SD) | Mean (SD) | Â |
25-hydroxyvitamin D (nmol/L) | 66.5 (20.5) | 64.8 (19.9) | 0.24 |
Total calcium (mg/dL) | 9.74 (0.39) | 9.72 (0.38) | 0.64 |
Intact Parathyroid hormone (pg/mL) | 31.2 (11.5) | 31.1 (11.6) | 0.92 |